Treatment of recurring cutaneous drug reactions in patients with human immunodeficiency virus 1 infection: A series of 3 cases

Archives of Dermatology

Volumn 140, Issue 9, 2004, Pages 1051-1053

  Dolev, Jacqueline ^a   Reyter, Ilya ^b   Maurer, Toby ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ATOVAQUONE; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DAPSONE; DEXAMETHASONE; DIDANOSINE; DOXYCYCLINE; EFAVIRENZ; ETHAMBUTOL; GANCICLOVIR; GLIBENCLAMIDE; IBUPROFEN; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; PENTAMIDINE; PREDNISONE; PYRIMETHAMINE; RITONAVIR; STAVUDINE; TESTOSTERONE; THALIDOMIDE; ZIDOVUDINE;

ADULT; ARTICLE; AVASCULAR NECROSIS; CASE REPORT; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; DRUG ERUPTION; ERYTHEMA MULTIFORME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; MALE; MYCOBACTERIOSIS; PHOTODERMATOSIS; PNEUMOCYSTIS PNEUMONIA; POLYPHARMACY; PRIORITY JOURNAL; RECURRENT DISEASE; RECURRENT DRUG ERUPTION;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG ERUPTIONS; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; MALE; PREDNISONE; RECURRENCE; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 4544240113     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.9.1051     Document Type: Article

References (15)

1. Coopman SA, Johnson RA, Platt R, et al. Cutaneous disease and drug reactions in HIV infection. N Engl J Med. 1993;328:1670-1674.
2. Smith KJ, Skelton HG, Yeager J, Ledsky R, Ng TH, Wagner KF; Military Medical Consortium for the Advancement of Retroviral Research (MMCARR). Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. Clin Exp Dermatol. 1997;22:118-123.
3. Heller HM. Adverse cutaneous drug reactions in patients with human immunodeficiency virus-1 infection. Clin Dermatol. 2000;18:485-489.
4. Dover JS, Johnson RA. Cutaneous manifestations of human immunodeficiency virus infection. Arch Dermatol. 1991;127:1383-1391.
5. Metry DW, Lahart CJ, Farmer KL, et al. Stevens-Johnson syndrome caused by the antiretroviral drug nevirapine. J Am Acad Dermatol. 2001;44:354-357.
6. Finkelstein M, Berman B. HIV and AIDS in inpatient dermatology. Dermatol Clin. 2000;18:509-520.
7. Stenzel MS, Carpenter CC. The management of the clinical complications of antiretroviral therapy. Infect Dis Clin North Am. 2000;14:851-878.
8. Caumes E, Roudier C, Rogeaux O, et al. Effect of corticosteroids on the incidence of adverse cutaneous reactions to trimethoprim-sulfamethoxazole during treatment of AIDS-associated Pneumocystis carinii pneumonia. Clin Infect Dis. 1994;18:319-323.
9. Lederman MM, Valdez H. Immune restoration with antiretroviral therapies. JAMA. 2000;284:223-228.
10. Koopmans PP, van der Ven AJ, van der Meer JW. Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: allergic or toxic? AIDS. 1995;9:217-222.
11. Nelson MR, Erskine D, Hawkins DA, et al. Treatment with corticosteroids-a risk factor for the development of clinical cytomegalovirus disease in AIDS. AIDS. 1993;7:375-378.
12. Gill PS, Loureiro C, Bernstein-Singer M, et al. Clinical effect of glucocorticoids on Kaposi's sarcoma related to the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1989;110:937-940.
13. Lambertus MW, Goetz MB, Murthy AR, et al. Complications of corticosteroid therapy in patients with the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Chest. 1990;98:38-43.
14. Brown P, Crane L. Avascular necrosis of bone in patients with human immunodeficiency virus infection: report of 6 cases and review of the literature. Clin Infect Dis. 2001;32:1221-1226.
15. McComseya GA, Whalena CC, Mawhorterb SD, et al. Placebo-controlled trial of prednisone in advanced HIV-1 infection. AIDS. 2001;15:321-327.